CRWV insider sale notice: $5.8M of RSU shares to be sold on NASDAQ

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filing reports a proposed sale of 56,294 common shares, acquired as restricted stock units on 08/05/2025. The broker listed is Morgan Stanley Smith Barney LLC and the sale is scheduled approximately for 09/02/2025 on NASDAQ. The filing shows an aggregate market value of $5,800,533.76 based on the proposed sale and reports 370,470,348 shares outstanding. No securities were sold by the reporting person in the past three months. The filer certifies they are unaware of undisclosed material adverse information and references Rule 10b5-1 procedures if applicable.

Insights

Securities Analyst

TL;DR Proposed sale is small relative to total shares outstanding and appears routine for RSU holders.

The filing documents a sale of 56,294 shares originating from restricted stock units granted on 08/05/2025, to be executed by Morgan Stanley Smith Barney on NASDAQ around 09/02/2025. The aggregate market value reported is $5,800,533.76 against 370,470,348 shares outstanding, making this sale a very small percentage of the float. There are no prior sales in the past three months reported, and the signer affirms no undisclosed material adverse information. From a market-impact perspective, this disclosure is standard and unlikely to move valuation metrics.

Corporate Governance Expert

TL;DR Disclosure aligns with Rule 144 requirements and includes the required attestation about material nonpublic information.

The notice contains required fields: acquisition date and nature (RSUs), broker details, intended sale date, and aggregate value. The absence of prior sales in the last three months simplifies aggregation rules. The attestation included addresses compliance with trading-plan and insider-information considerations. For governance oversight, this is a routine insider liquidity disclosure with no indications of unusual timing or regulatory concerns in the filing itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	56294	5800533.76	370470348	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/05/2025	Restricted Stock Units	Issuer			56294	08/05/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CoreWeave (CRWV) shares are proposed for sale in this Form 144?

The filing reports 56,294 common shares proposed for sale.

What is the aggregate market value of the proposed CRWV sale?

The aggregate market value reported is $5,800,533.76.

When were the shares acquired and what was the nature of acquisition?

The shares were acquired on 08/05/2025 as Restricted Stock Units (RSUs).

Which broker will handle the sale and on which exchange will CRWV trade?

The broker is Morgan Stanley Smith Barney LLC and the sale is to occur on NASDAQ.

Did the filer report any sales of CoreWeave securities in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.